日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Necroptosis in both tumour and stromal compartments determines responsiveness to immunogenic cell death-based immunotherapy

肿瘤和基质细胞中的坏死性凋亡决定了对基于免疫原性细胞死亡的免疫疗法的反应性。

Fernando, Winnie; Clucas, Jarama; Rizzo, Alberto; Singer, Ramsay; Goode, Emily; Tiu, Crescens; Layzell, Scott; Konecnik, Joshua; Wilson, Rebecca; Wicky John, Sidonie; Jouny, Samuel; Guppy, Naomi; Boulat, Victoire; Mannion, Jonathan; Goicoechea, Maria; Tan, Shaun; Lawson, Sam; Starling, Chris; Elshtein, Gabrielle; Ravindran, Nivedita; Montgomery, Anna B; Andres-Ejarque, Rosa; Allen, Mark; Lumbard, Steven; Wallberg, Fredrik; Betteridge, Kai; Scrimgeour, Ross; Robertson, David; Ward, George; Sims, Martin; Smyth, Tomoko; Samson, Andre L; Murphy, James M; Kolarevic Ivankovic, Daniela; Arwert, Esther N; Calado, Dinis P; Grigoriadis, Anita; Smalley, Matthew J; Melcher, Alan; Haider, Syed; Lawrence, Toby; Roxanis, Ioannis; Tutt, Andrew N J; Tenev, Tencho; Meier, Pascal

From single-sequences to evolutionary trajectories: protein language models capture the evolutionary potential of SARS-CoV-2

从单序列到进化轨迹:蛋白质语言模型捕捉SARS-CoV-2的进化潜力

Lamb, Kieran D; Hughes, Joseph; Lytras, Spyros; Young, Francesca; Koci, Orges; Herzig, James C; Lovell, Simon C; Grove, Joe; Yuan, Ke; Robertson, David L

Using a volitional help sheet to increase university students' attendance at on-campus lectures: A randomized controlled trial

利用自愿帮助表提高大学生校园讲座出勤率:一项随机对照试验

Elliott, Mark A; McGroarty, Allan; Robertson, David J; Anderson, Hazel P

Correction: Randomization in the age of platform trials: unexplored challenges and some potential solutions

更正:平台试验时代的随机化:尚未探索的挑战和一些潜在解决方案

Kuznetsova, Olga; Ross, Jennifer; Bodden, Daniel; Cooner, Freda; Chipman, Jonathan; Jacko, Peter; Krisam, Johannes; Luo, Yuqun Abigail; Mielke, Tobias; Robertson, David S; Ryeznik, Yevgen; Villar, Sofia S; Zhao, Wenle; Sverdlov, Oleksandr

Clinical Trial Simulation: Planning With the OCTAVE Framework, Implementation and Validation Principles

临床试验模拟:基于OCTAVE框架的规划、实施和验证原则

Lee, Kim May; Choodari-Oskooei, Babak; Grayling, Michael J; Jacko, Peter; Kimani, Peter K; Mukherjee, Aritra; Pallmann, Philip; Parke, Tom; Robertson, David S; Wang, Ziyan; Yap, Christina; Jaki, Thomas

Covariate Adjustment in Basket Trials Borrowing Information Across Subgroups

篮子试验中协变量调整:跨亚组借鉴信息

Ren, Jiyang; Robertson, David S; Zheng, Haiyan

The recency and geographical origins of the bat viruses ancestral to SARS-CoV and SARS-CoV-2

SARS-CoV 和 SARS-CoV-2 的祖先蝙蝠病毒的出现时间及其地理起源

Pekar, Jonathan E; Lytras, Spyros; Ghafari, Mahan; Magee, Andrew F; Parker, Edyth; Wang, Yu; Ji, Xiang; Havens, Jennifer L; Katzourakis, Aris; Vasylyeva, Tetyana I; Suchard, Marc A; Hughes, Alice C; Hughes, Joseph; Rambaut, Andrew; Robertson, David L; Dellicour, Simon; Worobey, Michael; Wertheim, Joel O; Lemey, Philippe

PLM-interact: extending protein language models to predict protein-protein interactions

PLM-interact:扩展蛋白质语言模型以预测蛋白质-蛋白质相互作用

Liu, Dan; Young, Francesca; Lamb, Kieran D; Claudio Quiros, Adalberto; Pancheva, Alexandrina; Miller, Crispin J; Macdonald, Craig; Robertson, David L; Yuan, Ke

Interpreting results from biomarker-guided clinical trials: avoiding "negative" or "failed" terminology

解读生物标志物指导的临床试验结果:避免使用“阴性”或“失败”等术语

Noor, Nurulamin M; Zheng, Haiyan; Robertson, David S; Savage, Joshua; Yap, Christina; Jorgensen, Andrea L; Wason, James M S

Practical guidance for conducting high-quality and rapid interim analyses in adaptive clinical trials

开展高质量、快速适应性临床试验中期分析的实用指南

Mossop, Helen; Walmsley, Zoë; Wilson, Nina; Agbeleye, Opeyemi; Bardgett, Michelle; Bevin-Nicholls, Alex; Breckons, Matthew; Cole, Michael; Craig, Dawn; Dimairo, Munyaradzi; Hancock, Helen; Law, Martin; Lopes, Andre; Noor, Nurulamin M; Oparah, Chizoba; Pallmann, Philip; Phillipson, Julia; Robertson, David S; Teare, M Dawn; Thomson, Katie H; Yap, Christina; Wason, James M S